Inquiry Basket
Loading ......
Filter By Product Search for
CAND1
CAND1 Full Name
cullin-associated and neddylation-dissociated 1
CAND1 Introduction
CAND1 (Cullin-Associated and Neddylation-Dissociated 1) is a highly conserved regulatory protein that plays a central role in controlling the activity of Cullin-RING E3 ubiquitin ligases (CRLs), one of the largest families of ubiquitin ligase complexes in eukaryotic cells. For researchers investigating protein degradation pathways, drug resistance mechanisms, or cellular homeostasis, understanding CAND1 is essential because it functions as a master regulator of CRL assembly and remodeling. Structurally, CAND1 wraps around cullin scaffold proteins and binds preferentially to unneddylated cullins, thereby preventing inappropriate recruitment of substrate receptor modules and maintaining the dynamic equilibrium of CRL complexes. This regulatory mechanism ensures that ubiquitination events occur with proper timing and substrate specificity. Studies over the past two decades have established CAND1 as a critical component of the cellular protein quality-control network, acting at the intersection of ubiquitination, proteostasis, signal transduction, and cell-cycle regulation.
The biological significance of CAND1 extends beyond simple inhibition of CRL activity. Rather than serving as a static suppressor, CAND1 functions as a substrate receptor exchange factor that facilitates the continuous recycling and reconfiguration of CRL complexes in response to changing cellular demands. Through coordinated interactions with cullins, the COP9 signalosome (CSN), and the neddylation machinery, CAND1 enables rapid exchange of F-box proteins and other substrate recognition modules, thereby expanding the substrate repertoire available to CRLs. This dynamic cycling mechanism allows cells to efficiently regulate numerous biological processes, including cell proliferation, DNA damage responses, immune signaling, metabolic adaptation, and developmental programs. Experimental studies have demonstrated that disruption of CAND1-mediated CRL remodeling can alter protein turnover rates, impair signaling fidelity, and disturb cellular homeostasis. As a result, CAND1 has emerged as a key molecular regulator of ubiquitin-dependent proteome remodeling and an important factor in maintaining normal cellular function.
Increasing evidence links CAND1 dysregulation to human disease, making it an attractive target for mechanistic research and therapeutic exploration. One notable example comes from metabolic disease, where reduced hepatic CAND1 expression has been observed in patients with non-alcoholic fatty liver disease (NAFLD) and in high-fat diet animal models. Mechanistic studies demonstrated that loss of CAND1 promotes assembly of the Cullin1–FBXO42 ubiquitin ligase complex, accelerating ubiquitination and degradation of acetyl-CoA acyltransferase 2 (ACAA2), a key enzyme involved in fatty acid β-oxidation. Consequently, CAND1 deficiency enhances lipid accumulation and liver injury, whereas restoration of CAND1 expression alleviates disease progression. Beyond metabolic disorders, aberrant CRL regulation involving CAND1 has been implicated in cancer biology, cardiovascular disease, and other pathological conditions characterized by altered protein degradation networks. Given its central position in controlling CRL plasticity and substrate selection, CAND1 is increasingly recognized as both a biomarker of ubiquitin-system dysfunction and a potential therapeutic node for diseases driven by dysregulated proteostasis and signaling pathways.
Alternate Names for CAND1
CAND1; cullin-associated and neddylation-dissociated 1; TIP120; TIP120A; cullin-associated NEDD8-dissociated protein 1; p120 CAND1; TBP interacting protein; TBP-interacting protein 120A; TBP-interacting protein of 120 kDa A; cullin-associated and neddylation-dissociated protein 1;
Loading ......
